Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

HilleVax, Inc. - Common Stock (NQ: HLVX )

1.900 +0.130 (+7.34%)
Streaming Delayed Price Updated: 3:10 PM EDT, Jul 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 959,014
Open 1.810
Bid (Size) 1.890 (10)
Ask (Size) 1.900 (62)
Prev. Close 1.770
Today's Range 1.780 - 1.900
52wk Range 1.550 - 20.22
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
HilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
(HLVX) - Analyzing HilleVax's Short Interest
Via Benzinga

Performance

YTD
-87.51%
-87.51%
1 Month
-85.46%
-85.46%
3 Month
-85.36%
-85.36%
6 Month
-87.52%
-87.52%
1 Year
-87.58%
-87.58%

More News

Read More
HilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Gold Falls Over 1%; HilleVax Shares Plunge
Via Benzinga
HLVX Stock Earnings: HilleVax Beats EPS for Q4 2023
Via InvestorPlace
Recap: HilleVax Q4 Earnings
Via Benzinga
Stocks Hold Steady, Small Caps Rise, French Equities Slip After Surprise Win By Left-Wing Bloc: What's Driving Markets Monday?
Via Benzinga
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
GRFS Stock Alert: Grifols Pops 20% on Takeover Interest
Via InvestorPlace
Why Is HilleVax (HLVX) Stock Down 87% Today?
Via InvestorPlace
HLVX Investors Have Opportunity to Join HilleVax, Inc. Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
Dow Turns Lower; Myomo Shares Jump
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Jumps Over 200 Points; Greenbrier Shares Fall After Q3 Results
Via Benzinga
Topics Stocks
Exposures US Equities
Vaccine Developer HilleVax Stock Nosedives On Monday - Here's Why
Via Benzinga
HilleVax Reports Topline Data from NEST-IN1 Phase 2b Clinical Study of HIL-214 in Infants
From HilleVax, Inc.
Via GlobeNewswire
Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Saia, Annexon, Core Scientific And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
Why Applied DNA Sciences Shares Are Trading Lower By Around 68%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
HLVX Stock Earnings: HilleVax Misses EPS for Q1 2024
Via InvestorPlace
HilleVax Reports First Quarter 2024 Financial Results and Highlights Recent Company Progress
From HilleVax, Inc.
Via GlobeNewswire
HilleVax Reports Full Year 2023 Financial Results and Highlights Recent Company Progress
From HilleVax, Inc.
Via GlobeNewswire
HilleVax to Present at Guggenheim 6th Annual Biotechnology Conference
From HilleVax, Inc.
Via GlobeNewswire
HilleVax Announces Executive Management Appointment of Sean McLoughlin as Chief Operating Officer
From HilleVax, Inc.
Via GlobeNewswire
Week In Review: China Biopharmas Book $9 Billion In Deals During JP Morgan Conference Week
Via Talk Markets
HilleVax and Kangh Announce Exclusive License Agreement for Hexavalent VLP Norovirus Vaccine Candidate Outside of China
From HilleVax, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.